Decoding Early Pulmonary Fibrosis by Examining the Cellular & Molecular Drivers of Disease Initiation

• Exploring the key cell populations and signaling pathways that drive the onset of pulmonary fibrosis in humans
• Identifying the molecular drivers, including transcriptional and epigenetic programs, that initiate fibrotic remodeling
• Detailing how understanding early disease mechanisms can inform biomarker discovery, patient stratification, and development of targeted interventions

Speakers:

Naftali Kaminski

Chief of Pulmonary, Critical Care, & Sleep Medicine

Yale Univerisity